vs
Side-by-side financial comparison of LANDMARK BANCORP INC (LARK) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
LANDMARK BANCORP INC is the larger business by last-quarter revenue ($18.8M vs $18.3M, roughly 1.0× ROCKWELL MEDICAL, INC.). LANDMARK BANCORP INC runs the higher net margin — 27.0% vs -3.0%, a 30.0% gap on every dollar of revenue. On growth, LANDMARK BANCORP INC posted the faster year-over-year revenue change (14.0% vs -25.6%). Over the past eight quarters, LANDMARK BANCORP INC's revenue compounded faster (13.1% CAGR vs -10.1%).
Landmark Bancorp Inc is a U.S.-based bank holding company operating Landmark National Bank, primarily serving communities across Kansas. It provides a full range of personal and commercial banking services including deposit accounts, residential mortgages, commercial loans, and wealth management solutions, catering to individual consumers, small businesses and local mid-sized enterprises.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
LARK vs RMTI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.8M | $18.3M |
| Net Profit | $5.1M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | — | -2.2% |
| Net Margin | 27.0% | -3.0% |
| Revenue YoY | 14.0% | -25.6% |
| Net Profit YoY | 7.8% | 26.7% |
| EPS (diluted) | — | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $18.8M | — | ||
| Q4 25 | $18.7M | $18.3M | ||
| Q3 25 | $18.2M | $15.9M | ||
| Q2 25 | $17.3M | $16.1M | ||
| Q1 25 | $16.5M | $18.9M | ||
| Q4 24 | $15.8M | $24.7M | ||
| Q3 24 | $15.9M | $28.3M | ||
| Q2 24 | $14.7M | $25.8M |
| Q1 26 | $5.1M | — | ||
| Q4 25 | $4.7M | $-554.0K | ||
| Q3 25 | $4.9M | $-1.8M | ||
| Q2 25 | $4.4M | $-1.5M | ||
| Q1 25 | $4.7M | $-1.5M | ||
| Q4 24 | $3.3M | $-756.0K | ||
| Q3 24 | $3.9M | $1.7M | ||
| Q2 24 | $3.0M | $343.0K |
| Q1 26 | — | — | ||
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% |
| Q1 26 | — | — | ||
| Q4 25 | 31.7% | -2.2% | ||
| Q3 25 | 33.4% | -9.9% | ||
| Q2 25 | 30.9% | -8.4% | ||
| Q1 25 | 34.7% | -7.2% | ||
| Q4 24 | 15.2% | -2.1% | ||
| Q3 24 | 30.3% | 6.8% | ||
| Q2 24 | 24.5% | 2.0% |
| Q1 26 | 27.0% | — | ||
| Q4 25 | 32.1% | -3.0% | ||
| Q3 25 | 27.1% | -11.0% | ||
| Q2 25 | 25.4% | -9.3% | ||
| Q1 25 | 28.5% | -8.0% | ||
| Q4 24 | 26.5% | -3.1% | ||
| Q3 24 | 24.8% | 5.9% | ||
| Q2 24 | 20.5% | 1.3% |
| Q1 26 | — | — | ||
| Q4 25 | $0.66 | $-0.01 | ||
| Q3 25 | $0.85 | $-0.05 | ||
| Q2 25 | $0.75 | $-0.05 | ||
| Q1 25 | $0.81 | $-0.04 | ||
| Q4 24 | $0.47 | $-0.02 | ||
| Q3 24 | $0.68 | $0.04 | ||
| Q2 24 | $0.52 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.9M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $37.0M |
| Total Assets | $1.6B | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $31.9M | — | ||
| Q4 25 | — | $10.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $12.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | — | $11.9M |
| Q1 26 | — | — | ||
| Q4 25 | $160.6M | $37.0M | ||
| Q3 25 | $155.7M | $37.0M | ||
| Q2 25 | $148.4M | $30.4M | ||
| Q1 25 | $142.7M | $31.5M | ||
| Q4 24 | $136.2M | $32.6M | ||
| Q3 24 | $139.7M | $29.1M | ||
| Q2 24 | $128.3M | $23.5M |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $57.1M | ||
| Q3 25 | $1.6B | $57.5M | ||
| Q2 25 | $1.6B | $52.6M | ||
| Q1 25 | $1.6B | $54.0M | ||
| Q4 24 | $1.6B | $59.2M | ||
| Q3 24 | $1.6B | $57.1M | ||
| Q2 24 | $1.6B | $53.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $21.6M | $2.3M | ||
| Q3 25 | $10.3M | $-1.3M | ||
| Q2 25 | $439.0K | $1.8M | ||
| Q1 25 | $8.0M | $-3.5M | ||
| Q4 24 | $14.2M | $865.0K | ||
| Q3 24 | $8.1M | $4.3M | ||
| Q2 24 | $4.4M | $1.4M |
| Q1 26 | — | — | ||
| Q4 25 | $21.0M | $2.2M | ||
| Q3 25 | $10.1M | $-1.5M | ||
| Q2 25 | $354.0K | $1.7M | ||
| Q1 25 | $8.0M | $-3.5M | ||
| Q4 24 | $11.9M | $470.0K | ||
| Q3 24 | $7.8M | $4.1M | ||
| Q2 24 | $3.8M | $1.2M |
| Q1 26 | — | — | ||
| Q4 25 | 112.5% | 12.0% | ||
| Q3 25 | 55.4% | -9.6% | ||
| Q2 25 | 2.0% | 10.5% | ||
| Q1 25 | 48.4% | -18.8% | ||
| Q4 24 | 75.6% | 1.9% | ||
| Q3 24 | 49.3% | 14.4% | ||
| Q2 24 | 25.6% | 4.5% |
| Q1 26 | — | — | ||
| Q4 25 | 3.2% | 0.5% | ||
| Q3 25 | 1.4% | 1.4% | ||
| Q2 25 | 0.5% | 1.0% | ||
| Q1 25 | 0.3% | 0.3% | ||
| Q4 24 | 14.7% | 1.6% | ||
| Q3 24 | 1.8% | 0.7% | ||
| Q2 24 | 4.2% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | 4.56× | — | ||
| Q3 25 | 2.09× | — | ||
| Q2 25 | 0.10× | — | ||
| Q1 25 | 1.71× | — | ||
| Q4 24 | 4.34× | — | ||
| Q3 24 | 2.06× | 2.57× | ||
| Q2 24 | 1.45× | 4.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LARK
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
